 |
PDBsum entry 6tyh
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
(+ 0 more)
22 a.a.
|
 |
|
|
|
|
|
|
|
28 a.a.
|
 |
|
|
|
|
|
|
|
29 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Novel four-Disulfide insulin analog with high aggregation stability and potency.
|
 |
|
Authors
|
 |
X.Xiong,
A.Blakely,
P.Karra,
M.A.Vandenberg,
G.Ghabash,
F.Whitby,
Y.W.Zhang,
M.J.Webber,
W.L.Holland,
C.P.Hill,
D.H.Chou.
|
 |
|
Ref.
|
 |
Chem Sci, 2020,
11,
195-200.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Although insulin was first purified and used therapeutically almost a century
ago, there is still a need to improve therapeutic efficacy and patient
convenience. A key challenge is the requirement for refrigeration to avoid
inactivation of insulin by aggregation/fibrillation. Here, in an effort to
mitigate this problem, we introduced a 4th disulfide bond between a
C-terminal extended insulin A chain and residues near the C-terminus of the B
chain. Insulin activity was retained by an analog with an additional disulfide
bond between residues A22 and B22, while other linkages tested resulted in much
reduced potency. Furthermore, the A22-B22 analog maintains the native insulin
tertiary structure as demonstrated by X-ray crystal structure determination. We
further demonstrate that this four-disulfide analog has similar in vivo
potency in mice compared to native insulin and demonstrates higher aggregation
stability. In conclusion, we have discovered a novel four-disulfide insulin
analog with high aggregation stability and potency.
|
 |
|
|
|
|
 |